• Noven Pharmaceuticals Inc., of Miami, said the FDA approved Brisdelle low-dose paroxetine capsules, 7.5 mg/day, for the treatment of moderate to severe vasomotor symptoms associated with menopause, the first nonhormonal treatment for hot flashes.